WHO ICTRP trial
Is it necessary to anticoagulate after EVLT combine GSV high ligation
ChiCTR-TRC-11002064 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TRC-11002064 |
|---|---|
| Public title | Is it necessary to anticoagulate after EVLT combine GSV high ligation |
| Scientific title | Is it necessary to anticoagulate after EVLT combine GSV high ligation |
| Primary sponsor | Bureau of Health, Shanghai |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Countries | China |
| Conditions | chronic vein insufficiency in lower limbs |
| Interventions | A:No anticoagulant;B:Low Molecular Heparin |
| Registration date | Feb 16, 2011 |
| Target size | A:100;B:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: